JP2020533313A5 - - Google Patents

Download PDF

Info

Publication number
JP2020533313A5
JP2020533313A5 JP2020513814A JP2020513814A JP2020533313A5 JP 2020533313 A5 JP2020533313 A5 JP 2020533313A5 JP 2020513814 A JP2020513814 A JP 2020513814A JP 2020513814 A JP2020513814 A JP 2020513814A JP 2020533313 A5 JP2020533313 A5 JP 2020533313A5
Authority
JP
Japan
Prior art keywords
aav
vector
tissue
group
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020513814A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020533313A (ja
JP7291125B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/049914 external-priority patent/WO2019051202A1/en
Publication of JP2020533313A publication Critical patent/JP2020533313A/ja
Publication of JP2020533313A5 publication Critical patent/JP2020533313A5/ja
Priority to JP2023065365A priority Critical patent/JP2023089148A/ja
Application granted granted Critical
Publication of JP7291125B2 publication Critical patent/JP7291125B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020513814A 2017-09-08 2018-09-07 神経障害性疼痛を処置するための方法および組成物 Active JP7291125B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023065365A JP2023089148A (ja) 2017-09-08 2023-04-13 神経障害性疼痛を処置するための方法および組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762556088P 2017-09-08 2017-09-08
US62/556,088 2017-09-08
PCT/US2018/049914 WO2019051202A1 (en) 2017-09-08 2018-09-07 METHOD AND COMPOSITION FOR TREATING NEUROPATHIC PAIN

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023065365A Division JP2023089148A (ja) 2017-09-08 2023-04-13 神経障害性疼痛を処置するための方法および組成物

Publications (3)

Publication Number Publication Date
JP2020533313A JP2020533313A (ja) 2020-11-19
JP2020533313A5 true JP2020533313A5 (https=) 2021-09-30
JP7291125B2 JP7291125B2 (ja) 2023-06-14

Family

ID=65634388

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020513814A Active JP7291125B2 (ja) 2017-09-08 2018-09-07 神経障害性疼痛を処置するための方法および組成物
JP2023065365A Pending JP2023089148A (ja) 2017-09-08 2023-04-13 神経障害性疼痛を処置するための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023065365A Pending JP2023089148A (ja) 2017-09-08 2023-04-13 神経障害性疼痛を処置するための方法および組成物

Country Status (8)

Country Link
US (1) US11707535B2 (https=)
EP (1) EP3678709A4 (https=)
JP (2) JP7291125B2 (https=)
KR (1) KR102640462B1 (https=)
CN (1) CN111093716B (https=)
AU (1) AU2018327253B2 (https=)
CA (1) CA3074587A1 (https=)
WO (1) WO2019051202A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025540164A (ja) * 2022-12-05 2025-12-11 ウジェ 427 痙縮を治療するためのgadをコードするウイルスベクター

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292722A (en) 1992-11-06 1994-03-08 Brigham And Women's Hospital Intravenous solution that diminishes body protein loss
US5643286A (en) 1994-06-24 1997-07-01 Cytotherapeutics, Inc. Microdrive for use in stereotactic surgery
US20020007145A1 (en) 1998-10-23 2002-01-17 Timothy Stivland Catheter having improved bonding region
CA2363254C (en) 1999-03-07 2009-05-05 Discure Ltd. Method and apparatus for computerized surgery
US20030069398A1 (en) * 2000-03-27 2003-04-10 Friedrich Rippmann Identification of human gaba transporter
WO2002020753A2 (en) 2000-09-01 2002-03-14 Lexicon Genetics Incorporated Human gaba transporter protein and polynucleotides encoding the same
US7011647B2 (en) 2001-07-13 2006-03-14 Scimed Life Systems, Inc. Introducer sheath
AU2005302408B2 (en) * 2004-10-28 2012-08-09 The Government of the United States of America as represented by the Department of Veterans Affairs Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain
ATE524121T1 (de) 2004-11-24 2011-09-15 Abdou Samy Vorrichtungen zur platzierung eines orthopädischen intervertebralen implantats
US20070213292A1 (en) 2005-08-10 2007-09-13 The Rockefeller University Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
WO2008010637A1 (en) * 2006-07-19 2008-01-24 Industry-Academic Cooperation Foundation, Yonsei University Composition for attenuating neuropathic pain comprising a recombinant vector expressing gad65
KR20080007968A (ko) 2006-07-19 2008-01-23 연세대학교 산학협력단 Gad65를 발현하는 재조합 벡터를 포함하는 신경병증성통증 완화용 조성물
EP2066791B1 (en) 2006-10-03 2012-09-12 Genzyme Corporation Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
US20100144538A1 (en) 2007-03-08 2010-06-10 Genizon Biosciences Inc. Genemap of the human genes associated with schizophrenia
CA2710969C (en) 2008-01-14 2016-02-09 I-V Access Technology, Inc. An apparatus for peripheral vascular access
EP2274041B1 (en) 2008-04-04 2016-06-08 The Cleveland Clinic Foundation Spinal platform for delivering a therapeutic agent to a spinal cord target
WO2010071832A1 (en) 2008-12-19 2010-06-24 Nationwide Children's Hospital Delivery of polynucleotides across the blood brain barrier using recombinant aav9
WO2011057171A1 (en) 2009-11-08 2011-05-12 Quark Pharmaceuticals, Inc. METHODS FOR DELIVERY OF siRNA TO THE SPINAL CORD AND THERAPIES ARISING THEREFROM
DK2621282T3 (da) 2010-09-28 2020-05-04 Univ California Gaba-agonister i behandlingen af forstyrrelser forbundet med metabolisk syndrom og gaba-kombinationer i behandling eller profylakse af type i diabetes
US20120310140A1 (en) 2010-12-01 2012-12-06 Spinal Modulation, Inc. Directed delivery of agents to neural anatomy
JP6188728B2 (ja) 2012-02-07 2017-08-30 グローバル・バイオ・セラピューティクス・インコーポレイテッドGlobal Bio Therapeutics,Inc. 核酸送達の区画化方法ならびにその組成物および使用
EP2897670A4 (en) 2012-09-24 2016-05-25 Univ California INJECTION SYSTEM FOR BACKMARK WITH PULSATION SUPPRESSION
WO2014116652A2 (en) * 2013-01-23 2014-07-31 The Regents Of The University Of California Method and composition for treating spasticity
GB201308917D0 (en) 2013-05-17 2013-07-03 Renishaw Plc Delivery
US10688285B2 (en) 2015-01-30 2020-06-23 The Regents Of The University Of California Spinal subpial gene delivery system
US20180008727A1 (en) 2015-01-30 2018-01-11 The Regents Of The University Of California Spinal subpial gene delivery system
KR20170034701A (ko) * 2015-09-21 2017-03-29 코오롱생명과학 주식회사 통증 치료용 조성물
AU2017241534A1 (en) * 2016-03-28 2018-10-04 The Regents Of The University Of California Method and composition for treating neuronal hyper-excitability

Similar Documents

Publication Publication Date Title
JP7395550B2 (ja) 新規アデノ随伴ウイルスキャプシドタンパク質
JP2021512649A5 (https=)
JP2021106619A5 (https=)
JP2020522269A5 (https=)
JP2022529631A5 (https=)
JP2022508182A5 (https=)
JP2021512072A5 (https=)
IL292999A (en) Compositions and methods of treating amyotrophic lateral sclerosis (als)
JP2020019772A5 (https=)
RU2018116076A (ru) Модифицированные гены атаксии фридрейха и векторы для генной терапии
JP2022549380A5 (https=)
RU2017115477A (ru) Полинуклеотиды aadc для лечения болезни паркинсона
JP2022535749A5 (https=)
JP2020519284A5 (https=)
JP2021522836A5 (https=)
JP2017529395A5 (https=)
JP2022551744A5 (https=)
JP2023524414A5 (https=)
JP2024508696A5 (https=)
JP2023537358A5 (https=)
JP2023553005A5 (https=)
JP2021520811A5 (https=)
JP2021534794A5 (https=)
JP2023520927A5 (https=)
JP2025513785A5 (https=)